Sustained remission after ruxolitinib and chimeric antigen receptor T-cell therapy bridged to a second allogeneic hematopoietic stem cell transplantation for relapsed Philadelphia chromosome-like B-cell precursor acute lymphoblastic leukemia with novel NPHP3-JAK2 fusion

Genes Chromosomes Cancer. 2022 Jan;61(1):55-58. doi: 10.1002/gcc.22995. Epub 2021 Sep 1.

Xue Chen¹, Lili Yuan¹, Jiarui Zhou², Fang Wang¹, Yang Zhang³, Xiaoli Ma¹, Panxiang Cao¹, Jiancheng Fang¹, Jiaqi Chen¹, Xiaosu Zhou³, Qisheng Wu⁴, Ming Liu¹, Hongxing Liu^{1

3

4}

¹ Division of Pathology & Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China.
² Department of Bone Marrow Transplantation, Hebei Yanda Lu Daopei Hospital, Langfang, China.
³ Molecular Medicine Research Center, Beijing Lu Daopei Institute of Hematology, Beijing, China.
⁴ Division of Pathology & Laboratory Medicine, Beijing Lu Daopei Hospital, Beijing, China.

No abstract available

Publication types